Adverse events11

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 11 of 11

Type	Event	Organ system	Group	Affected	At risk	Events
other	Pruritus	Skin and subcutaneous tissue disorders	All Participants (Topical Beremagene Geperpavec (B-VEC), and Placebo)	3	31	4
other	Erythema	Skin and subcutaneous tissue disorders	All Participants (Topical Beremagene Geperpavec (B-VEC), and Placebo)	2	31	2
other	Rash	Skin and subcutaneous tissue disorders	All Participants (Topical Beremagene Geperpavec (B-VEC), and Placebo)	2	31	2
other	Chills	General disorders	All Participants (Topical Beremagene Geperpavec (B-VEC), and Placebo)	3	31	3
other	Squamous cell carcinoma	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	All Participants (Topical Beremagene Geperpavec (B-VEC), and Placebo)	3	31	4
other	Cough	Respiratory, thoracic and mediastinal disorders	All Participants (Topical Beremagene Geperpavec (B-VEC), and Placebo)	2	31	2
other	Rhinorrhoea	Respiratory, thoracic and mediastinal disorders	All Participants (Topical Beremagene Geperpavec (B-VEC), and Placebo)	2	31	2
serious	Cellulitis	Infections and infestations	All Participants (Topical Beremagene Geperpavec (B-VEC), and Placebo)	1	31	1
serious	Diarrhoea	Gastrointestinal disorders	All Participants (Topical Beremagene Geperpavec (B-VEC), and Placebo)	1	31	1
serious	Anaemia	Blood and lymphatic system disorders	All Participants (Topical Beremagene Geperpavec (B-VEC), and Placebo)	1	31	2
serious	Blood culture positive	Investigations	All Participants (Topical Beremagene Geperpavec (B-VEC), and Placebo)	1	31	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04491604/events